Project Interface
Making Cancer Personal at the FDA
About Project Interface
Project Interface is the U.S. Food and Drug Administration’s Oncology Center of Excellence (OCE) outreach and engagement initiative. The project connects with domestic and global stakeholders, including patients diagnosed with cancer, patient advocacy organizations, and oncology experts.
Our mission is to protect, promote, and advance public health by organizing interactions with the American public to share critical information related to cancer awareness and treatment options. Our central theme is, “Making Cancer Personal at the FDA.”
Request a Meeting
Patient advocacy groups, faith-based organizations, and professional organizations are welcome to contact us to request a meeting. We are particularly interested in discussions about:
- Patient and caregiver experiences.
- Strengthening collaborations with international regulators
- Strategies to promote cancer awareness and lower cancer incidence
Meeting request webform: www.fda.gov/PatientsAskFDA
What We Do
- Coordinate listening sessions and meetings for patient advocates and stakeholders to engage with OCE staff about cancer-related topics, including specific topics like pediatric cancer.
- Support the White House Faith Office’s goal to “empower faith-based entities, community organizations, and houses of worship to better serve families and communities” through cancer-related engagement.
- Facilitate panel discussions on a wide range of cancer-specific topics.
- Publish plain-language information about cancer-related topics to make this science more accessible to the public.
Contact the Project Interface team at: OCE-Engagement@fda.hhs.gov
Further Information
Cancer Treatment Resources
- Oncology (Cancer)/Hematologic Malignancies Approval Notifications
- Project Patient Voice - Patient-reported outcomes from cancer clinical trials
Special Population Programs
General Resources
- Oncology Center of Excellence - Learn about OCE's mission and work
- Cancer Community Resources – Information about clinical trials and types of cancer
- Project Orbis - International collaboration for cancer treatment review